Importance of Magnetic Resonance Imaging (MRI) in Treating Breast Cancer

Stopped early · Not applicable

Conditions studied: Breast Cancer

In brief

The purpose of this study is to determine if the use of magnetic resonance imaging (MRI) for breast cancer translates into better surgical outcomes. MRIs may help ensure that as little healthy tissue is removed as is possible and may help prevent the need for additional surgical procedures.

Key facts

Study ID

NCT00948285

Run by

Texas Tech University Health Sciences Center

People needed

194

Starts

2009-07-01

Expected to finish

2018-12-01

Last updated by the study team

2019-11-13

Who can join

Age: 18 and older, up to 99. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Newly diagnosed breast cancer patients
• Breast cancer patients identified as conservation candidates by their surgeons

You may not qualify if…

• Patients with a history of prior breast cancer treatment (recurrence)
• Patients with breast cancer diagnosis during pregnancy (women who could bear children must have a negative pregnancy test before beginning this study)
• Patients with documented sensitivity to gadolinium (contrast agent used during MRI)
• Patients who weigh more than 350 pounds (weight limit on MRI machine)
• Patients who receive neoadjuvant chemotherapy
• Patients with renal insufficiency (serum Cr > 1.5) due to the danger of nephrogenic systemic sclerosis with the administration of Gadolinium

Where it is running

• Texas Tech University Health Sciences Center School of Medicine — Amarillo, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.